Coagulation Disorders Not Yet Recruiting Phase 1 / 2 Trials for Camostat (DB13729)

Also known as: Clotting Disorders / Disorders of Coagulation / Coagulopathies / Clotting Disorder / Blood Coagulation Disorder / Blood Coagulation Disorders / Disorders, Blood Coagulation / Blood Coagulation, Disorders / Coagulation Disorder, Blood / Coagulation Disorder / Coagulation defect / Coagulation Defects / Coagulopathy / Coagulation abnormal / (Coagulation defects) or (bleeding disorders) / Disorder of hemostatic system (disorder) / Disorder coagulation / Coagulation defect NOS (disorder) / Defect coagulation (NOS) / Blood coagulation disorder (disorder) / Disorder of hemostasis / Coagulation defect, unspecified / Coagulation disorder NOS / Coagulation disorder (NOS)

IndicationStatusPhase
DBCOND0030046 (Coagulation Disorders)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04435015The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular ComplicationsTreatment